Medical network - on September 8, according to the Chinese medicine and health products import and export chamber of commerce (hereinafter referred to as "medicare" chamber of commerce) the latest statistics, since 2009, our country export of pharmaceutical products were launched by nine countries a total of 77 cases of trade friction, involving 48 products, some of these products produce trade friction over and over again. Only in the first quarter this year, the health is dealt with by India, the United States and the European Union chamber of commerce launched six JianCi trade friction, saccharin, sanshui amoxicillin, efficient sweeteners, blood vessels, syringes, tartaric acid, and other products.
Niko zhang deputy director of the health care chamber of commerce, the ministry has said that in recent years, the world economy in the depth of the adjustment of a slow recovery, but the international market demand remains weak, under the background of this increased trade protectionism. With the acceleration of our country medicine enterprise internationalization, facing the pharmaceutical products in the export trade friction is on the rise, how to bypass the sea "rocks", become a joint project of the export-oriented enterprises.
Trade frictions are getting worse
According to the customs statistics, in January to June 2017, the total value of pharmaceutical products in China was 28,824,2404 million dollars, a year-on-year increase of 5.47%. The amount of imports was 269,296241 million, a year-on-year increase of 19.17 per cent. The pharmaceutical industry has steadily increased foreign trade. Trade friction, meanwhile, is rising.
By country, India is for Chinese medicinal products provoke trade friction most populous country, since 2009, a total of export of pharmaceutical products to me by 27 cases of anti-dumping investigation and 1 case of anti-evading investigation; Followed by the United States, initiated in eight years, a total of 19 cases of "337" investigation, 3 cases of anti-dumping investigation, 1 case and 1 case of anti-evading investigation antitrust lawsuits, including "337" investigation due to initiate an easy, simple process, wide jurisdiction, widespread, is the trade to our country enterprise the most lethal weapons; The third place is the European Union, which has launched 13 anti-dumping investigations against pharmaceutical products since 2009.
Niko zhang analysis, is the primary cause of trade friction caused by different trade country's competition, as well as our country medicine industry technology deficiency problem, overcapacity led to price competition, etc. She believes that the current trade frictions around China's pharmaceutical products present the following characteristics: first, trade frictions occur in traditional export markets such as India, the United States, the European Union and other countries.
Second, the amount involved is getting bigger and bigger. For example, the European Union has reexamined the Chinese tartaric acid sunset, which amounts to about $24 million. An anti-dumping investigation against Chinese patient monitors has been issued for $16 million. The us has launched an investigation into Chinese coenzyme Q10, which involved more than 60 million us dollars.
Third, the means of investigation are diversified. Although antidumping is still the main type of trade friction in China's pharmaceutical products, some developed countries, especially the United States, are increasingly at risk of initiating a "337" survey. In recent years, more than a third of the 337 investigations initiated by the United States are aimed at Chinese products. Niko zhang said that if a country enterprise by the "337" survey more intellectual property infringement, shows that companies in this country is going through transition throes, enterprises make each other feel threatened in intellectual property rights, belong to a kind of "growing pains". Japan and South Korea also experienced many "337" surveys during the 1990s economic boom.
Fourth, industry leading enterprises frequently become the subject of the case. China's foreign trade advantage products export enterprises are more concentrated, so it is easier to become the target of investigation.
Confront the reefs actively
Zhang beibei believes that trade friction has become a means of international market competition. She said, for example, in June 2011, Kaneka companies in Japan to the United States international trade commission filed a "337" survey application, accused of China, the United States, Japan's seven enterprise production and sale of coenzyme Q10 products to the United States of violating patents registered in the United States, including China's zhejiang medicine, xiamen golden da wei, shenzhou 3 companies. At the same time, zhejiang pharmaceutical has been sued in the United States and Germany for patent infringement. In September 2012, the U.S. international trade commission adopted the defense of Chinese companies. The 337 investigation, which lasted more than three years, has won three years of development and has had a negative impact on Chinese companies, although the Japanese company has lost the case. "Now many foreign enterprises have disrupted the strategic layout of our enterprises in the international market by provoking trade frictions." "Said zhang beibei.
According to understand, to help pharmaceutical companies cope with trade frictions, healthcare chamber of commerce actively play the role of industry organization and advantage, vigorously support related enterprises, provide enterprises with the whole process support, at the same time, strengthen and local government cooperation of the enterprise and the professional lawyer involved not only enhances the responses to the confidence of related companies, also has obtained the good effect. Summarize the experiences of years to deal with trade frictions, niko zhang pointed out: "the current our country medicine enterprise is more of a passive response to trade friction, if the enterprise to be able to trade friction layout in advance, positive coping, change from passive to deal with trade friction will mood to actively do a good job in risk control, the pharmaceutical enterprises in our country has the power through current throes of trade friction has the ability to turn bad things into good,, in turn, draw experience and lessons, completes the transformation and upgrading. For example, hangzhou baojing chemical industry co., LTD., in the face of eu anti-dumping investigation, has been actively responding to the eu anti-dumping investigation, which has not only succeeded, but also gained the eu market economy status. And Beijing yi-jia medical science and technology co., LTD., which lasted one and a half years and spent tens of millions of yuan, won the victory of the "337" lawsuit of the respiratory machine product. Their experience is worth learning from."
Zhou hui, President of the China health insurance association, believes that in the face of trade friction, Chinese companies need to overcome the fear, the fear and the fluke, and respond positively. Firstly, we should set up a consciousness to avoid the risk of trade friction. In the initial stage of trade, it is important to note whether there are any signs of friction and take the initiative to avoid risk. Secondly, once trade friction is encountered, enterprises should respond positively and quickly. Finally, the lawyer should be hired in time to respond professionally. (our reporter liu bo)
(note: the "337" survey "refers to the United States international trade commission according to the" 1930 year tax law "section 337 investigation and relevant amendments, aims to ban all ACTS of unfair competition and export to the United States or in any unfair trade practices.)
|
